As preliminary proof of concept for 3TC as a potential therapeutic in this context, we first analyzed a pre‐existing RNA‐seq dataset on cortex tissue from rTg4510 mice (a transgenic model of tauopathy due to the expression of mutant [P301L] human tau) (Castanho et al., 2020). The gene discussed is MAPT; the disease is tauopathy.